Saengboonmee相关文献与解析，生知库 | 链接生命科学的每一步

Fassl, Anne; Palacios Espinoza, Miriam; Butter, Deborah; Kolodziejczyk, Aleksandra; Seehawer, Marco; Hill, Charlotte; Ning, Xiaohan; Branigan, Timothy B; Peñailillo, Johany; Saengboonmee, Charupong; Jadhav, Heta; Charbonnier, Louis-Marie; Waks, Adrienne G; Strawser, Corinne; McDonnell, Donald P; Shapiro, Geoffrey I; Tolaney, Sara M; Polyak, Kornelia; Sammons, Sarah; Wucherpfennig, Kai W; Sicinski, Piotr

CDK4

CD155

信号转导

Glucosamine induces apoptosis of cholangiocarcinoma cells by suppressing high-mannose type N-glycosylation and EGFR/STAT3 signaling

葡萄糖胺通过抑制高甘露糖型N-糖基化和EGFR/STAT3信号通路诱导胆管癌细胞凋亡

期刊:Future Science OA

影响因子:2.1

doi:10.1080/20565623.2026.2641244

Waenphimai, Orawan; Taebprakhon, Cheerapinya; Phoomak, Chatchai; Chu, Chen; Silsirivanit, Atit; Wongkham, Sopit; Saengboonmee, Charupong

Editorial: Emerging horizons of metformin: exploring recent advances and addressing challenges in research and clinical utilization

社论：二甲双胍的新前景：探索最新进展并应对研究和临床应用中的挑战

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1674641

Saengboonmee, Charupong; Abbasi, Mehrnaz; Śliwińska, Agnieszka

发表日期：2025

文献求助收藏

Correction: Chiu et al. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. Cancers 2024, 16, 3513

更正：Chiu 等人，《肿瘤演化和治疗中代谢重编程的见解》，Cancers 2024, 16, 3513

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17040686

Chiu, Ching-Feng; Guerrero, Jonathan Jaime G; Regalado, Ric Ryan H; Zhou, Jiayan; Notarte, Kin Israel; Lu, Yu-Wei; Encarnacion, Paolo C; Carles, Cidne Danielle D; Octavo, Edrian M; Limbaroc, Dan Christopher I; Saengboonmee, Charupong; Huang, Shih-Yi

Molecular Mechanisms of Gemcitabine Resistance in Cholangiocarcinoma

胆管癌吉西他滨耐药的分子机制

期刊:Oncology Research

影响因子:4.1

doi:10.32604/or.2025.069027

Kidoikhammouan, Sonexai; Saengboonmee, Charupong; Wongkham, Sopit; Seubwai, Wunchana

Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma

利用纳米液相色谱-四极杆飞行时间串联质谱法（Nano-LC-QToF LC-MS/MS）进行血清N-糖组学分析，揭示胶质母细胞瘤、脑膜瘤和高级别脑膜瘤的N-糖生物标志物

期刊:Journal of Proteome Research

影响因子:3.6

doi:10.1021/acs.jproteome.4c01090

Silsirivanit, Atit; Alvarez, Michael Russelle S; Grijaldo-Alvarez, Sheryl Joyce; Gogte, Riya; Kitkhuandee, Amnat; Piyawattanametha, Nontaphon; Seubwai, Wunchana; Luang, Sukanya; Panawan, Orasa; Mahalapbutr, Panupong; Vaeteewoottacharn, Kulthida; Sawanyawisuth, Kanlayanee; Let-Itthiporn, Worachart; Saengboonmee, Charupong; Duangthongphon, Pichayen; Jingjit, Kritsakorn; Pankongsap, Anuchit; Waraasawapati, Sakda; Aphivatanasiri, Chaiwat; Lebrilla, Carlito B

Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma

胰高血糖素样肽-1受体激动剂：胆管癌治疗的潜在变革者

期刊:World Journal of Gastroenterology

影响因子:5.4

doi:10.3748/wjg.v30.i34.3862

Trakoonsenathong, Ronnakrit; Chiu, Ching-Feng; Saengboonmee, Charupong

Insights into Metabolic Reprogramming in Tumor Evolution and Therapy

肿瘤演变和治疗中代谢重编程的见解

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers16203513

Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma

白细胞介素-1β参与高糖激活胆管癌增殖

期刊:Translational Gastroenterology and Hepatology

影响因子:3.8

doi:10.21037/tgh-24-8

Kullanat Khawkhiaw, Surang Chomphoo, Waritta Kunprom, Kanyarat Thithuan, Supannika Sorin, Padcharee Yueangchantuek, Ching-Feng Chiu, Kazuo Umezawa, Jutatip Panaampon, Seiji Okada, Sopit Wongkham, Charupong Saengboonmee

Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo

利拉鲁肽在体外和体内对肝内胆管癌进展表现出潜在的抗肿瘤作用

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-024-64774-2

Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, Padcharee Yueangchantuek, Paslada Pimkeeree, Supannika Sorin, Kullanat Khawkhiaw, Ching-Feng Chiu, Seiji Okada, Sopit Wongkham, Charupong Saengboonmee

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6

细胞周期蛋白D-CDK4/6对免疫CD155-CD226-TIGIT轴的调控

Glucosamine induces apoptosis of cholangiocarcinoma cells by suppressing high-mannose type N-glycosylation and EGFR/STAT3 signaling

葡萄糖胺通过抑制高甘露糖型N-糖基化和EGFR/STAT3信号通路诱导胆管癌细胞凋亡

Editorial: Emerging horizons of metformin: exploring recent advances and addressing challenges in research and clinical utilization

社论：二甲双胍的新前景：探索最新进展并应对研究和临床应用中的挑战

Correction: Chiu et al. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. Cancers 2024, 16, 3513

更正：Chiu 等人，《肿瘤演化和治疗中代谢重编程的见解》，Cancers 2024, 16, 3513

Molecular Mechanisms of Gemcitabine Resistance in Cholangiocarcinoma

胆管癌吉西他滨耐药的分子机制

Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma

利用纳米液相色谱-四极杆飞行时间串联质谱法（Nano-LC-QToF LC-MS/MS）进行血清N-糖组学分析，揭示胶质母细胞瘤、脑膜瘤和高级别脑膜瘤的N-糖生物标志物

Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma

胰高血糖素样肽-1受体激动剂：胆管癌治疗的潜在变革者

Insights into Metabolic Reprogramming in Tumor Evolution and Therapy

肿瘤演变和治疗中代谢重编程的见解

Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma

白细胞介素-1β参与高糖激活胆管癌增殖

Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo

利拉鲁肽在体外和体内对肝内胆管癌进展表现出潜在的抗肿瘤作用